Friday, April 19, 2024
HomeTagsVenous thromboembolism

venous thromboembolism

FDA Approves Two New Indications for XARELTO (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics